ImportRefusal LogoImportRefusal

Novartis Consumer Health Inc.

⚠️ High Risk

FEI: 2244859 • Parsippany, NJ • UNITED STATES

FEI

FEI Number

2244859

📍

Location

Parsippany, NJ

🇺🇸
🏢

Address

200 Kimball Dr, , Parsippany, NJ, United States

High Risk

FDA Import Risk Assessment

53.6
LowModerateHighCritical

This firm has a significant history of FDA import refusals with notable violations.

Statistics

64
Total Refusals
5
Unique Violations
10/17/2019
Latest Refusal
8/27/2007
Earliest Refusal

Score Breakdown

Violation Severity
70.5×40%
Refusal Volume
67.2×30%
Recency
0.0×20%
Frequency
52.7×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

7535×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

11826×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

4733×

LABELING

The article appears in violation of FPLA because of its placement, form and/or contents statement.

32801×

FRNMFGREG

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.

3411×

REGISTERED

It appears the device is subject to listing under 510(j) and the initial distributor has not registered as required by 21 CFR 807.20 (a)(5).

Refusal History

DateProductViolationsDivision
10/17/2019
63HAY23SENNOSIDES A AND B (CATHARTIC)
118NOT LISTED
3280FRNMFGREG
Division of Northern Border Imports (DNBI)
11/13/2014
62OCB12VALSARTAN (ANTI-HYPERTENSIVE - PART II)
75UNAPPROVED
Cincinnati District Office (CIN-DO)
2/14/2013
62GBO18DICLOFENAC SODIUM (ANTI-INFLAMMATORY)
75UNAPPROVED
Division of Southeast Imports (DSEI)
8/24/2011
60LBZ01ACETAMINOPHEN (ANALGESIC)
118NOT LISTED
Florida District Office (FLA-DO)
8/24/2011
60LBR01ACETAMINOPHEN (ANALGESIC)
118NOT LISTED
Florida District Office (FLA-DO)
8/24/2011
60QAJ34DIBUCAINE (ANESTHETIC)
118NOT LISTED
Florida District Office (FLA-DO)
8/24/2011
66BAE05CAFFEINE (STIMULANT)
118NOT LISTED
Florida District Office (FLA-DO)
8/24/2011
62MAJ08MENTHOL (ANTI-PRURITIC)
118NOT LISTED
Florida District Office (FLA-DO)
8/24/2011
60SBL04ALUMINUM HYDROXIDE (ANTACID)
118NOT LISTED
Florida District Office (FLA-DO)
8/24/2011
60SBL14MAGNESIUM HYDROXIDE (ANTACID)
118NOT LISTED
Florida District Office (FLA-DO)
8/24/2011
60SBL04ALUMINUM HYDROXIDE (ANTACID)
118NOT LISTED
Florida District Office (FLA-DO)
8/24/2011
61VAA01SIMETHICONE (ANTI-FLATULENT)
118NOT LISTED
Florida District Office (FLA-DO)
8/24/2011
60LBA01ACETAMINOPHEN (ANALGESIC)
118NOT LISTED
Florida District Office (FLA-DO)
7/19/2011
77KCOINHALER, NASAL
118NOT LISTED
341REGISTERED
New York District Office (NYK-DO)
5/16/2011
60SBL04ALUMINUM HYDROXIDE (ANTACID)
118NOT LISTED
Florida District Office (FLA-DO)
5/16/2011
60LBL01ACETAMINOPHEN (ANALGESIC)
118NOT LISTED
Florida District Office (FLA-DO)
5/16/2011
60LBL01ACETAMINOPHEN (ANALGESIC)
118NOT LISTED
Florida District Office (FLA-DO)
5/16/2011
66BAA05CAFFEINE (STIMULANT)
75UNAPPROVED
Florida District Office (FLA-DO)
5/16/2011
60LBL01ACETAMINOPHEN (ANALGESIC)
75UNAPPROVED
Florida District Office (FLA-DO)
5/16/2011
60SBL04ALUMINUM HYDROXIDE (ANTACID)
75UNAPPROVED
Florida District Office (FLA-DO)
5/16/2011
60SBL04ALUMINUM HYDROXIDE (ANTACID)
75UNAPPROVED
Florida District Office (FLA-DO)
5/16/2011
60SBL04ALUMINUM HYDROXIDE (ANTACID)
75UNAPPROVED
Florida District Office (FLA-DO)
5/16/2011
60LBL01ACETAMINOPHEN (ANALGESIC)
75UNAPPROVED
Florida District Office (FLA-DO)
5/16/2011
60LBL01ACETAMINOPHEN (ANALGESIC)
75UNAPPROVED
Florida District Office (FLA-DO)
5/16/2011
60CBL49PHENYLPROPANOLAMINE HCL (ADRENERGIC)
75UNAPPROVED
Florida District Office (FLA-DO)
5/16/2011
66BAA05CAFFEINE (STIMULANT)
75UNAPPROVED
Florida District Office (FLA-DO)
5/16/2011
60SBL04ALUMINUM HYDROXIDE (ANTACID)
75UNAPPROVED
Florida District Office (FLA-DO)
5/16/2011
60SBL04ALUMINUM HYDROXIDE (ANTACID)
75UNAPPROVED
Florida District Office (FLA-DO)
5/16/2011
60SBL04ALUMINUM HYDROXIDE (ANTACID)
75UNAPPROVED
Florida District Office (FLA-DO)
5/16/2011
60SBL04ALUMINUM HYDROXIDE (ANTACID)
75UNAPPROVED
Florida District Office (FLA-DO)
5/11/2011
60CBL49PHENYLPROPANOLAMINE HCL (ADRENERGIC)
118NOT LISTED
Florida District Office (FLA-DO)
5/11/2011
60CBL49PHENYLPROPANOLAMINE HCL (ADRENERGIC)
118NOT LISTED
Florida District Office (FLA-DO)
5/11/2011
60SBL04ALUMINUM HYDROXIDE (ANTACID)
118NOT LISTED
Florida District Office (FLA-DO)
5/11/2011
60LOJ99ANALGESIC, N.E.C.
118NOT LISTED
Florida District Office (FLA-DO)
5/11/2011
60SBL04ALUMINUM HYDROXIDE (ANTACID)
118NOT LISTED
Florida District Office (FLA-DO)
5/11/2011
60SBL04ALUMINUM HYDROXIDE (ANTACID)
118NOT LISTED
Florida District Office (FLA-DO)
1/31/2011
60CBL49PHENYLPROPANOLAMINE HCL (ADRENERGIC)
118NOT LISTED
Florida District Office (FLA-DO)
1/31/2011
60CBL49PHENYLPROPANOLAMINE HCL (ADRENERGIC)
118NOT LISTED
Florida District Office (FLA-DO)
1/31/2011
60SBL04ALUMINUM HYDROXIDE (ANTACID)
75UNAPPROVED
Florida District Office (FLA-DO)
1/31/2011
60SBL04ALUMINUM HYDROXIDE (ANTACID)
75UNAPPROVED
Florida District Office (FLA-DO)
1/31/2011
60SBL04ALUMINUM HYDROXIDE (ANTACID)
75UNAPPROVED
Florida District Office (FLA-DO)
1/31/2011
60SBL04ALUMINUM HYDROXIDE (ANTACID)
75UNAPPROVED
Florida District Office (FLA-DO)
1/7/2011
60SBA04ALUMINUM HYDROXIDE (ANTACID)
75UNAPPROVED
Florida District Office (FLA-DO)
1/7/2011
60SBA04ALUMINUM HYDROXIDE (ANTACID)
75UNAPPROVED
Florida District Office (FLA-DO)
12/28/2010
60LBL01ACETAMINOPHEN (ANALGESIC)
75UNAPPROVED
Florida District Office (FLA-DO)
12/28/2010
60LBL01ACETAMINOPHEN (ANALGESIC)
75UNAPPROVED
Florida District Office (FLA-DO)
12/28/2010
66BAA05CAFFEINE (STIMULANT)
75UNAPPROVED
Florida District Office (FLA-DO)
12/28/2010
60LBC01ACETAMINOPHEN (ANALGESIC)
75UNAPPROVED
Florida District Office (FLA-DO)
12/28/2010
60LBC01ACETAMINOPHEN (ANALGESIC)
75UNAPPROVED
Florida District Office (FLA-DO)
12/28/2010
60LBA63SALICYLAMIDE (ANALGESIC)
75UNAPPROVED
Florida District Office (FLA-DO)
12/28/2010
61VBL01SIMETHICONE (ANTI-FLATULENT)
75UNAPPROVED
Florida District Office (FLA-DO)
12/28/2010
61VBL01SIMETHICONE (ANTI-FLATULENT)
75UNAPPROVED
Florida District Office (FLA-DO)
12/28/2010
60SBL04ALUMINUM HYDROXIDE (ANTACID)
75UNAPPROVED
Florida District Office (FLA-DO)
12/28/2010
60SBL04ALUMINUM HYDROXIDE (ANTACID)
75UNAPPROVED
Florida District Office (FLA-DO)
12/28/2010
63HBA23SENNOSIDES A AND B (CATHARTIC)
75UNAPPROVED
Florida District Office (FLA-DO)
11/9/2010
60CBL49PHENYLPROPANOLAMINE HCL (ADRENERGIC)
118NOT LISTED
Florida District Office (FLA-DO)
10/15/2010
60LBL01ACETAMINOPHEN (ANALGESIC)
473LABELING
Division of Southeast Imports (DSEI)
10/15/2010
60LBL01ACETAMINOPHEN (ANALGESIC)
473LABELING
Division of Southeast Imports (DSEI)
10/15/2010
60LBL01ACETAMINOPHEN (ANALGESIC)
473LABELING
Division of Southeast Imports (DSEI)
10/4/2010
60LBR01ACETAMINOPHEN (ANALGESIC)
75UNAPPROVED
Florida District Office (FLA-DO)
10/4/2010
62MAJ08MENTHOL (ANTI-PRURITIC)
75UNAPPROVED
Florida District Office (FLA-DO)
10/4/2010
60LAE66SODIUM SALICYLATE (ANALGESIC)
75UNAPPROVED
Florida District Office (FLA-DO)
8/27/2007
60LBY01ACETAMINOPHEN (ANALGESIC)
118NOT LISTED
San Juan District Office (SJN-DO)
8/27/2007
60LBY01ACETAMINOPHEN (ANALGESIC)
118NOT LISTED
San Juan District Office (SJN-DO)

Frequently Asked Questions

What is Novartis Consumer Health Inc.'s FDA import refusal history?

Novartis Consumer Health Inc. (FEI: 2244859) has 64 FDA import refusal record(s) in our database, spanning from 8/27/2007 to 10/17/2019.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Novartis Consumer Health Inc.'s FEI number is 2244859.

What types of violations has Novartis Consumer Health Inc. received?

Novartis Consumer Health Inc. has been cited for 5 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Novartis Consumer Health Inc. come from?

All FDA import refusal data for Novartis Consumer Health Inc. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.